CIK 0001789192
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Nexentis Technologies Inc.
Sign in to watch- Ticker
- NXTS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 264684680
- Phone
- +972 544561349
- Business address
- 156 FIFTH AVENUE 10TH FLOOR, CO EARTHBOUND LLC, NEW YORK, NY, 10010-7751
- Former names
- N2OFF, Inc., Save Foods, Inc., Save Foods Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-15 | Kalifi Udi Ovadia Director | Grant or award | +3,875 | 3,932 | ||
| 2026-10-15 | Itzhaik Asaf Director | Grant or award | +14,795 | 15,000 | ||
| 2026-10-15 | Palach David Chief Executive Officer | Grant or award | +101,549 | 120,000 | ||
| 2026-10-15 | Barda Lital Chief Financial Officer | Grant or award | +51,000 | 60,198 | ||
| 2026-10-15 | Berenstein Israel Yakov Director | Grant or award | +19,375 | 19,640 | ||
| 2026-10-15 | Weiss Amitay Director | Grant or award | +101,549 | 120,000 | ||
| 2026-10-15 | Zakai Shlomo Controller | Grant or award | +51,000 | 60,256 | ||
| 2026-10-15 | Rosenbloom Ronen Director | Grant or award | +19,375 | 19,640 | ||
| 2026-10-15 | Arbib Eliahou Director | Grant or award | +19,375 | 19,640 | ||
| 2026-10-15 | Sidi Liat Director | Grant or award | +14,795 | 15,000 | ||
| 2026-02-09 | Zakai Shlomo Controller | Grant or award | +50,000 | 64,778 | ||
| 2026-02-09 | Palach David Chief Executive Officer | Grant or award | +100,000 | 129,144 | ||
| 2026-02-09 | Weiss Amitay Director | Grant or award | +116,286 | 129,144 | ||
| 2026-02-09 | Barda Lital Chief Financial Officer | Grant or award | +50,000 | 64,370 | ||
| 2026-01-29 | Lee Eun Young 10% owner | Sale | −127 | $1.36 | $172 | 479,524 |
| 2025-05-12 | Barda Lital Chief Financial Officer | Grant or award | +300,000 | 502,857 | ||
| 2025-05-12 | Palach David Chief Executive Officer | Grant or award | +600,000 | 1,020,000 | ||
| 2024-12-23 | Sidi Liat Director | Grant or award | +50,000 | 50,000 | ||
| 2024-12-23 | Rosenbloom Ronen Director | Purchase | +50,000 | 64,500 | ||
| 2024-12-23 | Kalifi Udi Ovadia Director | Grant or award | +50,000 | 68,457 |
Page 1 of 3 · 42 trades